New drug will come onto the market in the near future.

Discussion in 'General Health & Wellness' started by jivayana, Jul 7, 2009.

  1. jivayana

    jivayana New Member



    JZP-6 (sodium oxybate)

    The Company is developing sodium oxybate, the active pharmaceutical ingredient in Xyrem, for the treatment of fibromyalgia. In November 2008, the Company announced the preliminary results from the first of two Phase III pivotal clinical trials of JZP-6 for the treatment of fibromyalgia. The randomized, double-blind, placebo-controlled study achieved its primary endpoints, demonstrating that JZP-6 decreased pain and fatigue, and improved daily function, in patients with fibromyalgia

    It will be brought to market by USB but is invented by JAZZ (= stockmarket ticker)

  2. TwoCatDoctors

    TwoCatDoctors New Member

    We have a separate Fibro board and you might want to put this on the Fibro board .